Interleukin 5 (IL-5) is the key cytokine involved in regulating the production and many of the specialized functions of mature eosinophils including priming, adhesion, and survival. We have generated a point mutant of human IL-5, IL-5 (E12K), which is devoid of agonist activity in both a TF-1 cell proliferation assay and a human eosinophil adhesion assay. However, IL-5 (E12K) is a potent and specific antagonist of both these IL-5–dependent functional responses. In both receptor binding and cross-linking studies the wild-type and IL-5 (E12K) mutant exhibit virtually identical properties. This mutant protein was unable to stimulate tyrosine phosphorylation in human eosinophils, and blocked the phosphorylation stimulated by IL-5. In contrast, IL-5 (E12K) is a full agonist in a human eosinophil survival assay, although with reduced potency compared to the wild-type protein. This IL-5 mutant enables us to clearly distinguish between two IL-5–dependent functional responses and reveals distinct mechanisms of receptor/cellular activation.
An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils
- Views Icon Views
- Share Icon Share
- Tools Icon Tools
- Search Site
Murray McKinnon, Kevin Page, Iain J. Uings, Martyn Banks, Dilniya Fattah, Amanda E.I. Proudfoot, Pierre Graber, Christian Arod, Richard Fish, Timothy N.C. Wells, Roberto Solari; An Interleukin 5 Mutant Distinguishes between Two Functional Responses in Human Eosinophils. J Exp Med 7 July 1997; 186 (1): 121–129. doi: https://doi.org/10.1084/jem.186.1.121
Download citation file: